February 17, 2023 in News Article Bluejay Diagnostics Signs Collaboration Agreement with Blood Centers of America
July 26, 2022 in News Article Bluejay Diagnostics, Inc. Reports Second Quarter 2022 Financial Results
June 9, 2022 in News Article Bluejay Reports FDA Agrees to Consider its Plan to Pursue a De Novo Regulatory Pathway for the Symphony IL-6 Test
April 21, 2022 in News Article Bluejay Diagnostics, Inc. Reports First Quarter 2022 Financial Results
March 28, 2022 in News Article Bluejay Diagnostics Appoints Edwin Rule as Vice President, Regulatory, Quality and Compliance
March 24, 2022 in News Article Bluejay Diagnostics Appoints Kenneth Fisher as Chief Financial Officer
January 31, 2022 in News Article Bluejay Diagnostics, Inc. Announces its Pre-Submission Filing Package for the Symphony IL-6 Test is with the FDA
January 5, 2022 in News Article Bluejay Diagnostics, Inc. Appoints Mark Feinberg, M.D. as Chief Medical Advisor
